CHRONIC USE OF PROTON PUMP INHIBITORS IS ASSOCIATED WITH AN INCREASED RISK OF IMMUNE CHECKPOINT INHIBITOR COLITIS IN RENAL CELL CARCINOMA

被引：0
|
作者：
Yin, Jianyi
Elias, Roy
Peng, Lan
Levonyak, Nicholas
Asokan, Annapoorani
Christie, Alana
Kubiliun, Nisa
Brugarolas, James
Hammers, Hans
机构：
来源：
GASTROENTEROLOGY | 2022年 / 162卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1248
引用
收藏
页码：S560 / S561
页数：2
相关论文
共 50 条
  • [41] Immune Checkpoint Inhibitors: Toward New Paradigms in Renal Cell Carcinoma
    Ronan Flippot
    Bernard Escudier
    Laurence Albiges
    Drugs, 2018, 78 : 1443 - 1457
  • [42] Biomarkers in metastatic renal cell carcinoma in the era of immune checkpoint inhibitors
    Tripathi, Abhishek
    Lin, Edwin
    Agarwal, Neeraj
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [43] Immune Checkpoint Inhibitors as Novel Targets for Renal Cell Carcinoma Therapeutics
    Bailey, Alexandra
    McDermott, David F.
    CANCER JOURNAL, 2013, 19 (04): : 348 - 352
  • [44] Pulmonary Metastasectomy after Immune Checkpoint Inhibitors in Renal Cell Carcinoma
    Sakanoue, Ichiro
    Hamaji, Masatsugu
    Nakajima, Daisuke
    Date, Hiroshi
    THORACIC AND CARDIOVASCULAR SURGEON, 2025, 73 (01): : 86 - 89
  • [45] Metastatic sarcomatoid renal cell carcinoma treated with immune checkpoint inhibitors
    Hanif, Ahmad
    Pandey, Manu
    Khan, Sumera
    Attwood, Kristopher
    George, Saby
    ONCOIMMUNOLOGY, 2019, 8 (08):
  • [46] Continuation of immune checkpoint inhibitors for newly developed brain metastasis during immune checkpoint inhibitor treatment for oligoprogressive metastatic renal cell carcinoma
    Ishihara, Hiroki
    Fukuda, Hironori
    Yoshida, Kazuhiko
    Hashimoto, Yasunobu
    Kondo, Tsunenori
    Takagi, Toshio
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (02) : 240 - 242
  • [47] Letter: association between the risk of microscopic colitis and use of proton pump inhibitors
    Liu, Yuanbin
    Chen, Mingkai
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (04) : 526 - 527
  • [48] The impact of statins and proton-pump inhibitors on immune checkpoint inhibition in patients with hepatocellular carcinoma
    Hobeika, B.
    Philipp, A. B.
    Piseddu, I.
    Schondorff, K.
    Enssle, S.
    Karin, M.
    Schneider, J.
    Reiter, F. P.
    Geier, A.
    Mayerle, J.
    Roessler, D. C.
    De Toni, E. N.
    Ben Khaled, N.
    ANNALS OF ONCOLOGY, 2024, 35 : S89 - S89
  • [49] Advanced Renal Cell Carcinoma: Tyrosine Kinase Inhibitors Versus Immune Checkpoint Inhibitors
    Rini, Brian I.
    ONCOLOGY-NEW YORK, 2022, 36 (08): : 511 - 515
  • [50] Combination of immune checkpoint inhibitors and tyrosine kinase inhibitors for the treatment of renal cell carcinoma
    Stuhler, Viktoria
    Rausch, Steffen
    Maas, Jan Moritz
    Stenzl, Arnulf
    Bedke, Jens
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (09) : 1215 - 1226
12345